There were 827 press releases posted in the last 24 hours and 183,883 in the last 365 days.

Global Antiviral Drugs Market Is Expected to Reach USD 51.67 Billion by 2028 : Fior Markets

Antiviral Drugs Market by Type (Branded, Generic), Product (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Integrase Inhibitors, Fusion Inhibitors, m-RNA Synthesis Inhibitors, Immune System Modulators and Combination Drugs), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2021 to 2028

/EIN News/ -- Newark, NJ, May 24, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global antiviral drugs market is expected to grow from USD 44.01 Billion in 2020 and to reach USD 51.67 Billion by 2028, growing at a CAGR of 2.0% during the forecast period 2021-2028.

The factors driving the market are growing surge in healthcare framework payout ability, the extent of a well-established supply chain, increasing interest to brace the evolution of novel antiviral drugs, advances in the formulation such as fixed-dose combination and soaring requirement of diseases specific treatment, arise in public awareness, improvement in the R&D segment, increase in virus infections such as influenza, respiratory syncytial virus, hepatitis, HIV swine flu, Ebola, Zika virus and coronavirus. The factors restraining the market growth are awareness about the accessibility of vaccines for several diseases, growing precautionary measures, rising need for different medicines like naturopathy and homeopathy, reducing the cost of therapy, high cost involved in the development of drugs, high price of research, treatment and strict government activities.

Antiviral Drugs are defined as disease-regulating agents against viral infections. The unique patents in anti-virus drugs are Tenofovir, Tamiflu, Relemza and Telbivudine, Sustiva have switched the anti-virus face. One after the other, these drugs influence viruses at different metabolic processes and swap the regular functioning of viral particles. In the past few years, resistance is detected between viruses in opposition to specific antiviral drugs with a growing diversity of microorganisms. This stimulation leads to broad-spectrum antiviral medicines that separately attack viruses at specified targets such as DNA polymerase, NS3 Protease and Reverse Transcriptase. Antiviral drugs are a class of antimicrobials, a big group that includes antibiotic, antifungal and antiparasitic drugs. These drugs prevent or cure different viral infections such as HIV/AIDS, Hepatitis, Influenza and other viral infections.

DOWNLOAD FREE SAMPLE REPORT AT https://www.fiormarkets.com/report-detail/419433/request-sample

Key players operating in the market are Dr. Reddy’s Laboratories Ltd, Abbott Laboratories, Aurobindo Pharma, Janssen Pharmaceuticals, Cosunter Pharmaceutical, Qingfeng Pharmaceutical, Regeneron Pharmaceuticals, Inovio Pharmaceuticals, Biocryst Pharmaceuticals, Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals Llc, Alembic Pharmaceuticals Limited,  Zydus Pharma, Gilead Sciences, Johnson & Johnson, Glaxosmithkline, Abbvie, Astrazeneca, Merck & Co, F. Hoffmann-La Roche Ag, Bristol-Myers Squibb Company, Cipla Inc, Schering-Plough Corporation, Pfizer Inc., Sanofi, Bausch Health, Novartis Ag, Mylan N.V., Chitai Tianqing, Novavax, Lupin, Laurus Labs Ltd and Micro Labs Ltd. To acquire a significant market share in the global antiviral drugs market, the pivotal players are now concentrating on adopting strategies such as product innovations, mergers & acquisitions, recent developments, joint ventures, collaborations, and partnerships.

  • In April 2020, Vanda Pharmaceuticals declared collaboration with the University of Illinois for R&D on novel Antiviral against coronavirus. This will generate business expansion opportunities for the company.

Branded Drugs segment dominated the market and held the largest market share of 54.0% in the year 2020
On the basis of type, the global antiviral drugs market is segmented into Branded and Generic. The Branded Drugs segment dominated the market and held the largest market share of 54.0% in the year 2020. This growth is attributed to its growing research and development cost combined with rapid FDA approval, the rising cost of branded drugs, increasing occurrence of infectious disease-related with high usage of branded medicines in HIV AIDS treatment.

Reverse Transcriptase Inhibitors Segment dominated the market and held the largest market share of 40.0% in the year 2020
On the basis of product, the global antiviral drugs market is segmented into DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Integrase Inhibitors, Fusion Inhibitors, m-RNA Synthesis Inhibitors, Immune System Modulators and Combination Drugs. The Reverse Transcriptase segment dominated the market and held the largest market share of 40.0% in the year 2020.

Browse full report with TOC at https://www.fiormarkets.com/report/antiviral-drugs-market-by-type-branded-generic-product-419433.html

Regional Segment of Antiviral Drugs Market

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Rest of APAC)
  • South America (Brazil and Rest of South America)
  • The Middle East and Africa (UAE, South Africa, Rest of MEA)

On the basis of geography, the global antiviral drugs market is classified into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America held the largest market share of 54.0% in the year 2020. This growth was accountable to the country witnessing a considerable increase in COVID-19 affected patients and this will fuel demand for Antiviral drugs.

Request for Customization: https://www.fiormarkets.com/enquiry/request-customization/419433

About the report:

The global antiviral drugs market is analyzed on the basis of value (USD Billion). All the segments have been analyzed on a global, regional and country basis. The study includes the analysis of more than 30 countries for each segment. The report offers an in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining key insights into the market. The study includes porter's five forces model, attractiveness analysis, raw material analysis, and competitors' position grid analysis.

For Instant Purchase: https://www.fiormarkets.com/checkout.html?reportid=419433&type=single

Customization of the Report:

The report can be customized as per client requirements. For further queries, you can contact us on sales@fiormarkets.com or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

About Fior Markets

Fior Markets is a futuristic market intelligence company, helping customers flourish their business strategies and make better decisions using actionable intelligence. With transparent information pool, we meet clients’ objectives, commitments on high standard and targeting possible prospects for SWOT analysis and market research reports. Fior Markets deploys a wide range of regional and global market intelligence research reports including industries like technology, pharmaceutical, consumer goods, food and beverages, chemicals, media, materials and many others. Our Strategic Intelligence capabilities are purposely planned to boost your business extension and elucidate the vigor of diverse industry. We hold distinguished units of highly expert analysts and consultants according to their respective domains. The global market research reports we provide involve both qualitative and quantitative analysis of current market scenario as per the geographical regions segregated and comprehensive performance in different regions with global approach. In addition, our syndicated research reports offer a packaged guide to keep companies abreast of the upcoming major restyle in their domains. Fior Markets facilitates clients with research analysis that are customized to their exact requirements, specifications and challenges, whether it is comprehensive desk research, survey work, composition of multiple methods, in-detailed interviewing or competitive intelligence. Our research experts are experienced in matching the exact personnel and methodology to your business need.

Contact Us

Avinash D
Head of Business Development
Phone: +1-201-465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com





To Know More Market Research Reports and Industry Analysis, Visit our Associate Website: https://marketandresearch.biz

Related Reports

Embolic Protection Devices Market - https://www.fiormarkets.com/report/embolic-protection-devices-market-by-product-distal-filters-419157.html
Dental Laser Market - https://www.fiormarkets.com/report/dental-laser-market-by-product-dental-welding-lasers-419155.html
Trauma Fixation Devices Market - https://www.fiormarkets.com/report/trauma-fixation-devices-market-by-type-internal-fixators-418958.html
Urinalysis Market - https://www.fiormarkets.com/report/urinalysis-market-by-product-consumables-instruments-application-liver-419175.html


Primary Logo